AQUINOX PHARMACEUTICALS INC's ticker is and the CUSIP is 03842B901. A total of 2 filers reported holding AQUINOX PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,000 | -42.9% | 1,900 | -24.0% | 0.00% | – |
| Q1 2019 | $7,000 | +600.0% | 2,500 | +316.7% | 0.00% | – |
| Q4 2018 | $1,000 | -97.6% | 600 | -95.9% | 0.00% | – |
| Q3 2018 | $42,000 | +2.4% | 14,500 | -7.1% | 0.00% | – |
| Q2 2018 | $41,000 | +192.9% | 15,600 | +1460.0% | 0.00% | – |
| Q1 2018 | $14,000 | -93.3% | 1,000 | -94.4% | 0.00% | -100.0% |
| Q4 2017 | $208,000 | +571.0% | 17,700 | +704.5% | 0.00% | – |
| Q3 2017 | $31,000 | -71.0% | 2,200 | -71.1% | 0.00% | -100.0% |
| Q2 2017 | $107,000 | +189.2% | 7,600 | +171.4% | 0.00% | – |
| Q3 2016 | $37,000 | – | 2,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 1,900 | $4,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |